Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.
about
CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitinHypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1α-CXCR4 axisDevelopment of a unique small molecule modulator of CXCR4Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern moleculesLow intensity pulsed ultrasound enhanced mesenchymal stem cell recruitment through stromal derived factor-1 signaling in fracture healingModulation of cocaine-induced activity by intracerebral administration of CXCL12i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4.Agarose Spot as a Comparative Method for in situ Analysis of Simultaneous Chemotactic Responses to Multiple ChemokinesSequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.HIV induces TRAIL sensitivity in hepatocytesMicrofluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxisCXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells.Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12.Dynamics and function of CXCR4 in formation of the granule cell layer during hippocampal development.Toxoplasma gondii is dependent on glutamine and alters migratory profile of infected host bone marrow derived immune cells through SNAT2 and CXCR4 pathways.The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesDiscovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.The intricate role of CXCR4 in cancer.SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasisImaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.CXC chemokine CXCL12 and its receptor CXCR4 in tree shrews (Tupaia belangeri): structure, expression and function.The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions.Cell, isoform, and environment factors shape gradients and modulate chemotaxisCord blood in regenerative medicine: do we need immune suppression?Initial assessment of the role of CXC chemokine receptor 4 after polytrauma.Periprostatic adipocytes act as a driving force for prostate cancer progression in obesityMast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppressionNovel inhibitors of the early steps of the HIV-1 life cycle.Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancerThe central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders?Epigenetic regulation of cardiac progenitor cells marker c-kit by stromal cell derived factor-1α64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.LPS response and tolerance in the zebrafish (Danio rerio)The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.Effects of exogenous ubiquitin in a polytrauma model with blunt chest trauma.
P2860
Q24302660-16F11179-D5C6-48E9-BB7C-3C312ED588EEQ27302080-8738D256-1EA4-4B3F-94D6-995EAE0C67CDQ27305638-415EE921-2D0B-4F5B-A5B9-41CEBA1E6E3AQ28289847-228005E9-D224-46CC-A2B7-9B623EEDA6B0Q28581375-8D2C8E04-DBAD-4CF2-9C96-C4AE571CBBA7Q28583243-20CC21CC-FC66-4A31-9AF1-D44264F07BDFQ30386356-4D00DD31-CCFB-4B71-9AA6-EFB79150EC24Q30850587-FDB5BB4D-BA27-45B6-884E-85296EE29662Q33409463-A539EFA6-FFAE-4C49-9C32-043A59B3EF5AQ33413051-791661DD-733D-46C7-84D7-903802262DABQ33668704-738CE8F5-7100-4D12-99FE-5FD8A37DCB5AQ33711863-01CCC6ED-BE11-42BA-BFAD-88C4D8E29B04Q33725587-94B4F43D-07E6-4096-9B9F-0E0AA3D0F5D0Q33765419-7B72ED12-5902-4240-99ED-BEEAF037C9FCQ33767336-F2F95F76-9BC3-447C-8A84-4383EA75CB7AQ33911801-C518D510-8AEB-4720-9321-DE485DD9338BQ34317872-6EB71058-6134-4666-8D03-78C5150B18F3Q34432943-C43EEA4A-D35C-432D-9475-D57F51052682Q34994758-536BE567-B929-4B79-B4DF-FE316335B71FQ35036663-F4728044-8395-4B4C-B8DF-3701464A9F86Q35067624-BC1FD43F-62C4-4A73-826C-4934540DC051Q35123087-2634A0A6-DAA5-4650-9CA5-102CF033450DQ35131138-79E34FE4-8E35-4022-83AE-0A401802DD08Q35161921-C14870A7-62F1-4F2B-B94B-C47126E28870Q35173452-3A12957F-EFA4-4FDA-A122-0A9C5292E75FQ35312229-24CF6003-7CC2-477E-ABEF-A34F38582E9CQ35613631-D46FC3ED-FB6B-4D76-8B4A-E69263745503Q35633105-46C673C5-6F0B-458C-953F-6368F5BF4263Q36327374-F52EE90B-9AD7-4FCD-9431-ABEA6E611A8BQ36511320-DF358FC7-E90C-41AB-BB21-C146513F5712Q36668031-975F5912-6A65-4416-9F59-279BE875D51EQ36677383-ACF9873F-4E6B-4C85-8F5E-885D7F6646BDQ36806897-3588BC10-36F5-496A-9D03-BBA01CED7CDEQ36999566-6457B93F-0385-4CC3-9B19-312F9650B7BEQ37016290-9EB53E3B-7985-4B58-8E06-2B8297735402Q37042691-4B9D3DDB-299A-43D7-A4D9-5B4BF9D2201BQ37297085-4347A2F2-39AF-4B31-AB68-B1E409882F9AQ37356543-244226CE-B4CF-4298-8A11-43B366C14C1BQ37397999-E81A5B57-250E-4729-BFD8-AF7D9BD01ABEQ37457104-EAC41CEC-EC53-4975-AC37-EF9E2C74D2AE
P2860
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@en
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@nl
type
label
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@en
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@nl
prefLabel
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@en
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@nl
P2093
P1476
Characterization of the molecu ...... led chemokine receptor, CXCR4.
@en
P2093
Gloria Lau
Jean Labrecque
Jennifer Cox
Kim L Nelson
Marilyn C Darkes
Ognjen Grujic
Rebecca S Y Wong
Renee M Mosi
Simon P Fricker
P304
P356
10.1016/J.BCP.2006.05.010
P407
P577
2006-07-03T00:00:00Z